Paul Peter Tak - Nov 29, 2024 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Executive Officer, Director
Signature: /s/ Charles Schoch, as Attorney-in-Fact for Paul Peter Tak
Stock symbol: CADL
Transactions as of: Nov 29, 2024
Transactions value $: -$222,527
Form type: 4
Date filed: 12/3/2024, 05:48 PM
Previous filing: Nov 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CADL	Common Stock	Sale	-$223K	-48.8K	-14.21%	$4.56	295K	Nov 29, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Content

The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.